Cellectis Net Income vs. Cash Per Share
| CLLS Stock | USD 3.90 0.09 2.26% |
Net Loss | First Reported 2012-09-30 | Previous Quarter -23.7 M | Current Value 589 K | Quarterly Volatility 14.5 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.026 | 0.0274 |
|
|
For Cellectis profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Cellectis to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Cellectis SA utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Cellectis's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Cellectis SA over time as well as its relative position and ranking within its peers.
Cellectis | Build AI portfolio with Cellectis Stock |
Is there potential for Biotechnology market expansion? Will Cellectis introduce new products? Factors like these will boost the valuation of Cellectis. Projected growth potential of Cellectis fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Cellectis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.33) | Revenue Per Share | Quarterly Revenue Growth 1.059 | Return On Assets | Return On Equity |
The market value of Cellectis SA is measured differently than its book value, which is the value of Cellectis that is recorded on the company's balance sheet. Investors also form their own opinion of Cellectis' value that differs from its market value or its book value, called intrinsic value, which is Cellectis' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Cellectis' market value can be influenced by many factors that don't directly affect Cellectis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Cellectis' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cellectis should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Cellectis' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cellectis SA Cash Per Share vs. Net Income Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Cellectis's current stock value. Our valuation model uses many indicators to compare Cellectis value to that of its competitors to determine the firm's financial worth. Cellectis SA is rated third in net income category among its peers. It is number one stock in cash per share category among its peers . At this time, Cellectis' Net Loss is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Cellectis by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Cellectis Cash Per Share vs. Net Income
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Cellectis |
| = | (36.7 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Cellectis |
| = | 3.37 X |
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Cellectis Cash Per Share Comparison
Cellectis is currently under evaluation in cash per share category among its peers.
Cellectis Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Cellectis, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Cellectis will eventually generate negative long term returns. The profitability progress is the general direction of Cellectis' change in net profit over the period of time. It can combine multiple indicators of Cellectis, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -45.5 M | -47.7 M | |
| Operating Income | -53.6 M | -56.3 M | |
| Income Before Tax | -33.1 M | -34.7 M | |
| Total Other Income Expense Net | 20.5 M | 21.5 M | |
| Net Loss | -33 M | -34.7 M | |
| Income Tax Expense | -5.8 M | -6.1 M | |
| Net Loss | -33.1 M | -34.7 M | |
| Net Loss | -95.5 M | -100.3 M | |
| Interest Income | 13 M | 13.6 M | |
| Net Interest Income | 3.4 M | 3.6 M | |
| Change To Netincome | 5.4 M | 5.1 M | |
| Net Loss | (0.47) | (0.49) | |
| Income Quality | (0.72) | (0.68) | |
| Net Income Per E B T | 0.78 | 0.62 |
Cellectis Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Cellectis. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Cellectis position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Cellectis' important profitability drivers and their relationship over time.
Cellectis Earnings Estimation Breakdown
The calculation of Cellectis' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Cellectis is estimated to be -0.155 with the future projection ranging from a low of -0.155 to a high of -0.155. Please be aware that this consensus of annual earnings estimates for Cellectis SA is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.15 Lowest | Expected EPS | -0.15 Highest |
Cellectis Earnings Projection Consensus
Suppose the current estimates of Cellectis' value are higher than the current market price of the Cellectis stock. In this case, investors may conclude that Cellectis is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Cellectis' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2026 | Current EPS (TTM) | |
| 5 | 56.11% | 0.0 | -0.155 | -0.33 |
Cellectis Earnings per Share Projection vs Actual
Actual Earning per Share of Cellectis refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Cellectis SA predict the company's earnings will be in the future. The higher the earnings per share of Cellectis, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Cellectis Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Cellectis, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Cellectis should always be considered in relation to other companies to make a more educated investment decision.Cellectis Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Cellectis' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
null | null | null | null | null | 0 | ||
2025-11-07 | 2025-09-30 | -0.2338 | 0.01 | 0.2438 | 104 | ||
2025-08-04 | 2025-06-30 | -0.2 | -0.24 | -0.04 | 20 | ||
2025-05-13 | 2025-03-31 | -0.24 | -0.17 | 0.07 | 29 | ||
2025-03-14 | 2024-12-31 | -0.09 | -0.16 | -0.07 | 77 | ||
2024-11-04 | 2024-09-30 | -0.21 | -0.23 | -0.02 | 9 | ||
2024-08-06 | 2024-06-30 | -0.3 | -0.28 | 0.02 | 6 | ||
2024-04-29 | 2024-03-31 | -0.22 | -0.7 | -0.48 | 218 | ||
2024-03-13 | 2023-12-31 | -0.22 | -0.7 | -0.48 | 218 | ||
2023-11-06 | 2023-09-30 | -0.42 | -0.31 | 0.11 | 26 | ||
2023-08-03 | 2023-06-30 | -0.45 | -0.19 | 0.26 | 57 | ||
2023-05-04 | 2023-03-31 | -0.48 | -0.58 | -0.1 | 20 | ||
2023-03-08 | 2022-12-31 | -0.71 | -0.59 | 0.12 | 16 | ||
2022-11-03 | 2022-09-30 | -0.46 | -0.63 | -0.17 | 36 | ||
2022-08-04 | 2022-06-30 | -0.56 | -0.42 | 0.14 | 25 | ||
2022-05-12 | 2022-03-31 | -0.68 | -0.7 | -0.02 | 2 | ||
2022-03-03 | 2021-12-31 | -0.92 | -0.55 | 0.37 | 40 | ||
2021-12-09 | 2021-09-30 | -0.8 | -0.82 | -0.02 | 2 | ||
2021-08-05 | 2021-06-30 | -0.73 | -0.88 | -0.15 | 20 | ||
2021-05-06 | 2021-03-31 | -0.81 | -0.28 | 0.53 | 65 | ||
2021-03-04 | 2020-12-31 | -0.78 | -0.95 | -0.17 | 21 | ||
2020-11-05 | 2020-09-30 | -0.61 | -0.69 | -0.08 | 13 | ||
2020-08-06 | 2020-06-30 | -0.74 | -0.76 | -0.02 | 2 | ||
2020-05-06 | 2020-03-31 | -0.65 | 0.47 | 1.12 | 172 | ||
2020-03-05 | 2019-12-31 | -0.77 | -0.88 | -0.11 | 14 | ||
2019-11-07 | 2019-09-30 | -0.8 | -0.38 | 0.42 | 52 | ||
2019-08-06 | 2019-06-30 | -0.6 | -0.79 | -0.19 | 31 | ||
2019-05-07 | 2019-03-31 | -0.68 | -0.36 | 0.32 | 47 | ||
2019-03-11 | 2018-12-31 | -0.71 | -0.53 | 0.18 | 25 | ||
2018-11-13 | 2018-09-30 | -0.61 | -0.54 | 0.07 | 11 | ||
2018-08-01 | 2018-06-30 | -0.62 | -0.17 | 0.45 | 72 | ||
2018-05-07 | 2018-03-31 | -0.7 | -0.71 | -0.01 | 1 | ||
2018-03-12 | 2017-12-31 | -0.72 | -0.76 | -0.04 | 5 | ||
2017-11-01 | 2017-09-30 | -0.58 | -0.73 | -0.15 | 25 | ||
2017-08-03 | 2017-06-30 | -0.55 | -0.75 | -0.2 | 36 | ||
2017-05-10 | 2017-03-31 | -0.61 | -0.57 | 0.04 | 6 | ||
2017-03-17 | 2016-12-31 | -0.38 | -0.38 | 0.0 | 0 | ||
2016-11-22 | 2016-09-30 | -0.68 | -0.32 | 0.36 | 52 | ||
2016-09-08 | 2016-06-30 | -0.4 | -0.2 | 0.2 | 50 | ||
2016-05-12 | 2016-03-31 | -0.49 | -0.5 | -0.01 | 2 | ||
2016-03-16 | 2015-12-31 | -0.3 | 0.65 | 0.95 | 316 | ||
2015-11-19 | 2015-09-30 | -0.3 | -0.4 | -0.1 | 33 | ||
2015-09-09 | 2015-06-30 | -0.36 | -0.63 | -0.27 | 75 | ||
2015-06-09 | 2015-03-31 | -0.04 | 0.26 | 0.3 | 750 |
Use Cellectis in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cellectis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cellectis will appreciate offsetting losses from the drop in the long position's value.Cellectis Pair Trading
Cellectis SA Pair Trading Analysis
The ability to find closely correlated positions to Cellectis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cellectis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cellectis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cellectis SA to buy it.
The correlation of Cellectis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cellectis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cellectis SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cellectis can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Cellectis position
In addition to having Cellectis in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Impulse Thematic Idea Now
Impulse
Large corporations operating in retail, broadcasting, energy, airlines and telecom sectors. The Impulse theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Impulse Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Cellectis Stock Analysis
When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.